Literature DB >> 30904934

Anesthetics' role in postoperative urinary retention after pelvic organ prolapse surgery with concomitant midurethral slings: a randomized clinical trial.

Alexandriah Alas1, Laura Martin2, Hemikaa Devakumar2, Lawrence Frank2, Sneha Vaish2, Neeraja Chandrasekaran2, G Willy Davila2, Eric Hurtado2.   

Abstract

INTRODUCTION AND HYPOTHESIS: Spinal anesthesia can be a potential risk factor for postoperative urinary retention (POUR). Our objective was to compare POUR rates for outpatient vaginal pelvic floor surgeries when using spinal versus general anesthesia. Our hypothesis was that spinal anesthesia would have higher POUR rates compared with general anesthesia.
METHODS: This was a randomized clinical trial on subjects undergoing outpatient pelvic organ prolapse (POP) surgery with a concomitant midurethral sling (MUS). Subjects were discharged home the same day as surgery. Subjects were excluded if they had a preoperative post-void residual > 150 ml, they were < 40 years of age, surgery was < 1 h, or they had contraindications to spinal or general anesthesia. A standardized voiding trial was performed. The primary aim was to compare POUR rates between anesthesia groups. A power analysis estimated 28 subjects were required per group to detect a 37% difference with 80% power and an alpha of 0.05.
RESULTS: The trial was registered at ClinicalTrials.gov on July 15, 2015. Sixty-one subjects were enrolled between June 22, 2015, and December 31, 2017. Three were excluded, leaving 29 in each group. Groups were similar in demographics. For the primary outcome, there was a 14.3% difference in POUR rates between spinal and general anesthesia, which did not reach statistical significance based on our power calculation (p = 0.2516).
CONCLUSIONS: Based on this study, there is not an increased rate of POUR with the use of spinal anesthesia for POP surgery with MUS. However, since there was a trend toward higher rates of POUR in the spinal group, it is possible that a larger powered study design would be able to detect a statistically significant difference between the groups. Based on these findings, if surgical patients would benefit from spinal anesthesia, the risk of urinary retention should not be considered a reason to not utilize this form of anesthesia. CLINICAL TRIAL REGISTRATION: Does spinal anesthesia for prolapse surgery with concomitant sling lead to an increase in urinary retention compared to general anesthesia? https://clinicaltrials.gov/ct2/show/NCT02547155?term=laura+martin&rank=3 (NCT02547155).

Entities:  

Keywords:  Midurethral slings; Pelvic organ prolapse; Postoperative urinary retention; Spinal anesthesia

Mesh:

Year:  2019        PMID: 30904934     DOI: 10.1007/s00192-019-03917-w

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  34 in total

1.  Predicting short-term urinary retention after vaginal prolapse surgery.

Authors:  Robert A Hakvoort; Marcel G Dijkgraaf; Matthe P Burger; Mark H Emanuel; Jan Paul W R Roovers
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

2.  Retropubic versus transobturator midurethral slings for stress incontinence.

Authors:  Holly E Richter; Michael E Albo; Halina M Zyczynski; Kimberly Kenton; Peggy A Norton; Larry T Sirls; Stephen R Kraus; Toby C Chai; Gary E Lemack; Kimberly J Dandreo; R Edward Varner; Shawn Menefee; Chiara Ghetti; Linda Brubaker; Ingrid Nygaard; Salil Khandwala; Thomas A Rozanski; Harry Johnson; Joseph Schaffer; Anne M Stoddard; Robert L Holley; Charles W Nager; Pamela Moalli; Elizabeth Mueller; Amy M Arisco; Marlene Corton; Sharon Tennstedt; T Debuene Chang; E Ann Gormley; Heather J Litman
Journal:  N Engl J Med       Date:  2010-05-17       Impact factor: 91.245

3.  Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15.

Authors:  Peter A Stark; Paul S Myles; Justin A Burke
Journal:  Anesthesiology       Date:  2013-06       Impact factor: 7.892

4.  Post operative voiding efficacy after anterior colporrhaphy.

Authors:  Roya Kokabi; Zhila Fereidouni; Mohammad Hassan Meshkibaf; Behnoosh Miladpoor
Journal:  Acta Med Iran       Date:  2010 Jan-Feb

5.  Postoperative voiding dysfunction following posterior colporrhaphy.

Authors:  Nicole M Book; Brian Novi; Joseph M Novi; James Q Pulvino
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 Jan-Feb       Impact factor: 2.091

6.  Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence.

Authors:  Bumsik Hong; Sungchan Park; Hong Sik Kim; Myung-soo Choo
Journal:  J Urol       Date:  2003-09       Impact factor: 7.450

7.  Postoperative urinary retention in gynecologic patients.

Authors:  B Bødker; G Lose
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-04-23

8.  Spinal morphine anesthesia and urinary retention.

Authors:  K T Mahan; J Wang
Journal:  J Am Podiatr Med Assoc       Date:  1993-11

9.  Predicting postoperative voiding efficiency after operation for incontinence and prolapse.

Authors:  Steven Kleeman; Steven Goldwasser; Brett Vassallo; Mickey Karram
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

10.  Factors that are associated with clinically overt postpartum urinary retention after vaginal delivery.

Authors:  Michael E Carley; Janine M Carley; Gary Vasdev; Timothy G Lesnick; Maurice J Webb; Kirk D Ramin; Raymond A Lee
Journal:  Am J Obstet Gynecol       Date:  2002-08       Impact factor: 8.661

View more
  2 in total

1.  Effect Observation on Modified Zishen Tongguan Decoction Combined with Acupuncture in Treatment of Urinary Retention after Cervical Cancer Surgery and Its Influence on the Incidence of Adverse Reactions.

Authors:  Shujuan Wang; Min Wang; Hongbin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-13       Impact factor: 2.629

2.  Predictors of prolonged admission after outpatient female pelvic reconstructive surgery.

Authors:  Andrea M Simi; Graham C Chapman; Jacqueline Zillioux; Sarah Martin; Emily A Slopnick
Journal:  Neurourol Urodyn       Date:  2022-03-29       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.